Co-Authors
This is a "connection" page, showing publications co-authored by Naim Ata and Kürsat Dal.
Connection Strength
0.176
-
COVID-19 clinical course and blood groups: Turkish population-based study Turk J Med Sci. 2021 08 30; 51(4):1659-1664.
Score: 0.060
-
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med. 2022 01; 17(1):135-139.
Score: 0.059
-
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020 Oct; 26(7):1676-1682.
Score: 0.056